Literature DB >> 29366768

Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.

Hong Shen1, Xue-Jiao Gao2, Ting Li2, Wang-Hui Jing2, Bei-Lei Han2, Yu-Meng Jia2, Nan Hu2, Zhi-Xiang Yan2, Song-Lin Li3, Ru Yan4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Polysaccharides and small molecules commonly co-exist in decoctions of traditional Chinese medicines (TCMs). Our previous study outlined that ginseng polysaccharides (GP) could interact with co-existing ginsenosides to produce synergistic effect in an over-fatigue and acute cold stress model via gut microbiota involved mechanisms. AIM OF THE STUDY: This study aimed to verify the interactions by examining the impact of GP on oral pharmacokinetics of ginsenoside Rb1 (Rb1), the dominant protopanoxadiol (PPD)-type ginsenoside in Ginseng, on a dextran sulphate sodium (DSS) induced experimental colitis model which was characterized by gut dysbiosis, and to delineate the underlying mechanisms in vitro.
MATERIALS AND METHODS: Rats received drinking water (normal group), 5% DSS (UC group), or 5% DSS plus daily oral administration of GP (GP group) for 7 days and fecal samples were collected on day -3, 0 and 6. On day 7 all animals received an oral dosage of Rb1 and blood samples were withdrawn for pharmacokinetic study. The in vitro metabolism study of Rb1 in gut microbiota from normal and UC rats and the transport study of Rb1 across Caco-2 cell monolayer were carried out in presence/absence of GP. Rb1 and its bacterial metabolites ginsenoside Rd (Rd), ginsenoside F2 (F2), Compound K (CK) and PPD were determined using LC-MS/MS. Total and target bacteria in fecal samples were determined by using 16S rRNA-based RT-PCR. β-Glucosidase activity was determined by measuring 4-nitrophenol formed from 4-nitrophenyl-β-D-glucopyranoside hydrolysis.
RESULTS: DSS induction did not alter AUC0-t and Cmax of Rb1, which, however, were doubled together with elevated AUC0-t of the metabolites, in particular Rd and CK, in GP group. GP influenced the microbial composition and showed a prebiotic-like effect. Accordingly, GP treatment could partially restore the β-glucosidase activity which was reduced by DSS induction. The presence of GP resulted in quicker microbial metabolism of Rb1 and higher Rd formation in first 8 h of incubation, while the impact on F2 and CK formation/conversion became obvious after 8 h. More interestingly, GP slightly stimulated Caco-2 cell growth and facilitated Rb1 transport across the Caco-2 monolayer in both directions, increasing the Papp of Rb1 from 10-7 cm/s to 10-6 cm/s.
CONCLUSIONS: GP alleviated DSS-induced colitis-like symptoms and enhanced the systemic exposure of Rb1 through enhancing microbial deglycosylation and intestinal epithelial absorption of Rb1. These findings further demonstrated the important role of gut microbiota in the multifaceted action of polysaccharides in the holistic actions of traditional decoction of TCMs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29366768     DOI: 10.1016/j.jep.2018.01.021

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  19 in total

Review 1.  Current Status and Problem-Solving Strategies for Ginseng Industry.

Authors:  Xiang-Yan Li; Li-Wei Sun; Da-Qing Zhao
Journal:  Chin J Integr Med       Date:  2019-10-15       Impact factor: 1.978

Review 2.  The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis.

Authors:  Tristan St-Laurent; Riadh Hammami
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

3.  Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.

Authors:  Jianping Deng; Zicong Wu; Zhenling Zhao; Chaoxi Wu; Min Yuan; Zhengquan Su; Yifei Wang; Zhiping Wang
Journal:  Int J Nanomedicine       Date:  2020-06-03

Review 4.  Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.

Authors:  Wuwen Feng; Hui Ao; Cheng Peng
Journal:  Front Pharmacol       Date:  2018-11-23       Impact factor: 5.810

5.  Ophiopogon Polysaccharide Promotes the In Vitro Metabolism of Ophiopogonins by Human Gut Microbiota.

Authors:  Huai-You Wang; Shu-Chen Guo; Zhi-Tian Peng; Cheng Wang; Ran Duan; Tina T X Dong; Karl W K Tsim
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

Review 6.  Anti-Inflammatory Diets and Fatigue.

Authors:  Ulrike Haß; Catrin Herpich; Kristina Norman
Journal:  Nutrients       Date:  2019-09-30       Impact factor: 5.717

Review 7.  Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?

Authors:  Lin Li; Senjie Zhong; Bin Cheng; Hong Qiu; Zhixi Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-06       Impact factor: 2.629

Review 8.  Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles.

Authors:  Qing Zhao; Xin Luan; Min Zheng; Xin-Hui Tian; Jing Zhao; Wei-Dong Zhang; Bing-Liang Ma
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

Review 9.  Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases.

Authors:  Ajay Srivastava; Rajiv Lall; Jamil Talukder; Dan DuBourdieu; Ramesh C Gupta
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

10.  Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Eunhak Seong; Shambhunath Bose; Song-Yi Han; Eun-Ji Song; Myeongjong Lee; Young-Do Nam; Hojun Kim
Journal:  EPMA J       Date:  2021-06-03       Impact factor: 8.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.